Swedish Exchange Showcases Three Growth Companies With High Insider Ownership

In This Article:

As global markets respond to a mix of easing inflation and varied economic signals, the Swedish stock exchange presents a unique landscape for investors interested in growth companies with high insider ownership. This focus can offer insights into firms where leadership has significant skin in the game, potentially aligning management's interests with those of shareholders especially in an environment marked by shifting economic indicators.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

21.6%

Biovica International (OM:BIOVIC B)

18.5%

73.8%

edyoutec (NGM:EDYOU)

14.6%

63.1%

Sileon (OM:SILEON)

20.3%

109.3%

KebNi (OM:KEBNI B)

37.8%

90.4%

Yubico (OM:YUBICO)

37.5%

43.8%

InCoax Networks (OM:INCOAX)

18.1%

104.9%

BioArctic (OM:BIOA B)

34%

50.9%

Calliditas Therapeutics (OM:CALTX)

11.6%

52.9%

SaveLend Group (OM:YIELD)

23.3%

103.4%

Click here to see the full list of 87 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

BioArctic

Simply Wall St Growth Rating: ★★★★★★

Overview: BioArctic AB, based in Sweden, specializes in developing biological drugs for central nervous system disorders and has a market capitalization of SEK 20.85 billion.

Operations: The company generates SEK 252.21 million from its biotechnology segment, focusing on biological drugs for central nervous system disorders.

Insider Ownership: 34%

Earnings Growth Forecast: 50.9% p.a.

BioArctic, a Swedish biopharma firm with significant insider ownership, has recently seen approval in South Korea for its Alzheimer's treatment, Leqembi®, enhancing its product portfolio. Despite a challenging Q1 in 2024 with a shift from profit to loss, the company is poised for recovery with anticipated high revenue growth (40.8% per year) and return to profitability within three years. Strategic alliances like the ongoing collaboration with Eisai Co., Ltd., underscore its commitment to innovation in Alzheimer's therapy.

OM:BIOA B Earnings and Revenue Growth as at Jul 2024
OM:BIOA B Earnings and Revenue Growth as at Jul 2024

Pandox

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB (publ) is a global hotel property company that owns, develops, and leases hotel properties with a market capitalization of approximately SEK 38.33 billion.

Operations: The company generates revenue primarily through two segments: own operation, which brought in SEK 3.27 billion, and rental agreements, contributing SEK 3.82 billion.